HER2: A protein that is overexpressed in certain types of breast cancer. EGFR: A receptor that is often mutated in lung and colorectal cancers. BRAF: A gene that, when mutated, can lead to melanoma and other cancers. PD-1/PD-L1: Immune checkpoints that are targeted by immunotherapies to enhance the body’s immune response against cancer cells.
